Skip to main content
Caplight Logo









Cellia Science, Inc.

Cellia Science, Inc.

Private
Fayetteville, ArkansasHealthcare & Life Scienceshttps://celliasci.com/

Last Round

Grant

Sep 16, 2025

Total Funding Raised

$2.58M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Cellia Science, Inc. is a medical device company that develops and commercializes point-of-care hematology analyzers using label-free deep-UV imaging technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS

AI Layer

Application

Keywords

point-of-care diagnosticshematology analyzerPOC testingblood cell countmedical devicelabel-free imagingmicrofluidic cartridgedeep-UV imagingCLIA-waivedwhite blood cell differentialcomputer visionmedtechclinical diagnosticsdigital pathologylab-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cellia Science, Inc. Comparables

Compare Cellia Science, Inc. with similar companies based on industry and business-model similarity.

Cellia Science, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sight Diagnostics
78%
Soulbrain Holdings Co. Ltd
76%
Commure
76%

Cellia Science, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 16, 2025
GrantJun 13, 2025
GrantAug 17, 2023
GrantFeb 13, 2023
SeedApr 20, 2022

Key People

Founding team and executive leadership

Kelly Mabry

Co-Founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 16, 2025

    $307K grant from National Institute of Allergy and Infectious Diseases and NIH RADx.

  • Feb 13, 2023

    $276K grant received from NHLBI and NIH RADx.

Cellia Science, Inc. Filings

Explore SEC and related filing metadata, where available.

Cellia Science, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cellia Science, Inc.'s valuation, stock price, and market status.

Is Cellia Science, Inc. a public or private company?

Cellia Science, Inc. is a private company.

What is the current stock price of Cellia Science, Inc.?

Cellia Science, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Cellia Science, Inc. worth (valuation)?

Valuation information for Cellia Science, Inc. is not publicly available.

Can I buy Cellia Science, Inc. stock?

Cellia Science, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cellia Science, Inc.'s last funding round?

Cellia Science, Inc.'s most recent funding round was Grant on September 16, 2025.

Who are the main investors in Cellia Science, Inc.?

Key investors in Cellia Science, Inc. include VIC Technology Venture Development.

Will Cellia Science, Inc. IPO soon?

No public IPO plans have been announced for Cellia Science, Inc..

How can I track Cellia Science, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cellia Science, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFayetteville, Arkansas
Employee Range4
Year Founded2021
Last FundingSep 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?